• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Harvard Bioscience (NQ: HBIO )

    3.300 +0.170 (+5.43%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Jul 23, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 125,303
    Open 3.100
    Bid (Size) 3.290 (7)
    Ask (Size) 3.300 (14)
    Prev. Close 3.130
    Today's Range 3.100 - 3.300
    52wk Range 2.700 - 5.560
    Shares Outstanding 42,688,246
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Holley And 2 Other Stocks Under $5 Insiders Are Buying
    Via Benzinga
    FlexShopper And 3 Other Stocks Under $5 Insiders Are Buying
    Via Benzinga

    Performance

    YTD
    -38.78%
    -38.78%
    1 Month
    +15.79%
    +15.79%
    3 Month
    -10.81%
    -10.81%
    6 Month
    -26.83%
    -26.83%
    1 Year
    -33.87%
    -33.87%

    More News

    Read More
    Harvard Bioscience, Inc. to Present and Host One-on-One Meetings at the 14th Annual East Coast IDEAS Conference on June 12, 2024
    From Harvard Bioscience, Inc.
    Via GlobeNewswire
    Harvard Bioscience, Inc. to Present at the Jefferies Global Healthcare Conference on June 5, 2024
    From Harvard Bioscience, Inc.
    Via GlobeNewswire
    A Preview Of Harvard Bioscience's Earnings
    Via Benzinga
    Earnings Preview For Harvard Bioscience
    Via Benzinga
    Harvard Bioscience, Inc. to Participate in the Benchmark Healthcare House Call Virtual Conference
    From Harvard Bioscience, Inc.
    Via GlobeNewswire
    HBIO Stock Earnings: Harvard Bioscience Meets EPS, Misses Revenue for Q1 2024
    Via InvestorPlace
    Harvard Bioscience Announces First Quarter 2024 Financial Results
    From Harvard Bioscience, Inc.
    Via GlobeNewswire
    Harvard Bioscience Schedules First Quarter 2024 Earnings Conference Call for May 7, 2024 at 8:00 AM ET
    From Harvard Bioscience, Inc.
    Via GlobeNewswire
    Harvard Bioscience Announces Action to Improve Operational Efficiency and Support Ongoing Investments in Growth
    From Harvard Bioscience, Inc.
    Via GlobeNewswire
    Harvard Bioscience, Inc. to Participate in March 2024 Investor Conferences: Sidoti’s Small Cap Conference and KeyBanc’s Life Sciences & MedTech Conference
    From Harvard Bioscience, Inc.
    Via GlobeNewswire
    HBIO Stock Earnings: Harvard Bioscience Misses EPS, Misses Revenue for Q4 2023
    Via InvestorPlace
    Harvard Bioscience Announces Fourth Quarter 2023 Financial Results
    From Harvard Bioscience, Inc.
    Via GlobeNewswire
    Earnings Scheduled For March 7, 2024
    Via Benzinga
    Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Society of Toxicology Meeting
    From Harvard Bioscience, Inc.
    Via GlobeNewswire
    Harvard Bioscience Schedules Fourth Quarter 2023 Earnings Conference Call for March 7, 2024 at 8:00 AM ET
    From Harvard Bioscience, Inc.
    Via GlobeNewswire
    Harvard Bioscience to Present at Benchmark Company’s Discovery One-On-One Investor Conference on December 7, 2023
    From Harvard Bioscience, Inc.
    Via GlobeNewswire
    Harvard Bioscience to Present at Southwest IDEAS Investor Conference on November 16, 2023
    From Harvard Bioscience, Inc.
    Via GlobeNewswire
    Harvard Bioscience Announces Third Quarter 2023 Financial Results
    From Harvard Bioscience, Inc.
    Via GlobeNewswire
    Harvard Bioscience to Showcase Latest Innovations in Preclinical and Organoid Research at Society for Neuroscience Conference on November 12-15, 2023
    From Harvard Bioscience, Inc.
    Via GlobeNewswire
    Harvard Bioscience Schedules Third Quarter 2023 Earnings Conference Call for November 7, 2023 at 8:00 AM ET
    From Harvard Bioscience, Inc.
    Via GlobeNewswire
    Harvard Bioscience and Etisense Announce Agreement for Supply and Distribution of DECRO Miniature Telemetry Jacket Platform for Pre-Clinical Research
    From Harvard Bioscience, Inc.; Etisense
    Via GlobeNewswire
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    Harvard Bioscience Announces Second Quarter 2023 Financial Results
    From Harvard Bioscience, Inc.
    Via GlobeNewswire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.